Zymeworks

From WikiMD's Food, Medicine & Wellness Encyclopedia

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia

Zymeworks Logo.svg

Products and areas of focus[edit | edit source]

Zymeworks develops protein therapeutics for the treatment of:

  1. cancer
  2. autoimmune diseases and
  3. inflammatory diseases.

Molecular modelling[edit | edit source]

The products are based upon the company's molecular modeling software for optimizing protein structure.

Funding[edit | edit source]

  • In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year.
  • In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million.
  • This was the largest Canadian biotech IPO in more than a decade.

Trivia[edit | edit source]

By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.

Leadership[edit | edit source]

Website[edit | edit source]


News Resources
General Organizations By Region
Types Roles Related

{{This 'news' related article is a stub.}}


This article is a stub.

Help WikiMD grow by registering to expand it.
Editing is available only to registered and verified users.
About WikiMD: A comprehensive, free health & wellness encyclopedia.

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Retrieved from "https://wikimd.com/w/index.php?title=Zymeworks&oldid=4142191"

Contributors: Prab R. Tumpati, MD